Emerald Mutual Fund Advisers Trust Lowers Stock Holdings in Integer Holdings Corporation $ITGR

Emerald Mutual Fund Advisers Trust lowered its holdings in Integer Holdings Corporation (NYSE:ITGR) by 35.0% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 16,593 shares of the medical equipment provider’s stock after selling 8,919 shares during the period. Emerald Mutual Fund Advisers Trust’s holdings in Integer were worth $1,460,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the stock. Tudor Investment Corp ET AL boosted its stake in shares of Integer by 50,787.5% during the third quarter. Tudor Investment Corp ET AL now owns 29,500,000 shares of the medical equipment provider’s stock worth $28,606,000 after buying an additional 29,442,029 shares during the period. Vanguard Group Inc. grew its holdings in shares of Integer by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 3,886,150 shares of the medical equipment provider’s stock worth $304,791,000 after purchasing an additional 14,465 shares during the period. State Street Corp increased its holdings in Integer by 3.7% in the 4th quarter. State Street Corp now owns 1,371,767 shares of the medical equipment provider’s stock valued at $107,588,000 after purchasing an additional 48,463 shares in the last quarter. Viking Global Investors LP boosted its stake in shares of Integer by 9.1% during the 2nd quarter. Viking Global Investors LP now owns 1,283,965 shares of the medical equipment provider’s stock valued at $157,889,000 after buying an additional 106,692 shares during the last quarter. Finally, Irenic Capital Management LP bought a new position in shares of Integer during the fourth quarter worth about $99,109,000. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have commented on ITGR shares. Citigroup upped their target price on shares of Integer from $92.00 to $96.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. Zacks Research lowered Integer from a “hold” rating to a “strong sell” rating in a report on Monday, May 11th. Weiss Ratings reissued a “hold (c)” rating on shares of Integer in a research report on Thursday, June 18th. Finally, Piper Sandler reiterated an “overweight” rating and set a $97.00 price target (up from $87.00) on shares of Integer in a report on Friday, May 1st. Four analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Integer currently has an average rating of “Hold” and a consensus target price of $99.29.

Integer Stock Up 2.9%

NYSE ITGR opened at $96.40 on Tuesday. The stock’s 50 day simple moving average is $90.82 and its 200 day simple moving average is $87.08. The company has a debt-to-equity ratio of 0.77, a current ratio of 3.75 and a quick ratio of 2.38. Integer Holdings Corporation has a one year low of $62.00 and a one year high of $120.41. The firm has a market cap of $3.27 billion, a PE ratio of 24.04, a price-to-earnings-growth ratio of 2.23 and a beta of 0.64.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.21 by ($0.01). Integer had a return on equity of 12.83% and a net margin of 7.64%.The company had revenue of $439.58 million for the quarter, compared to analyst estimates of $426.48 million. During the same quarter last year, the company earned $1.31 EPS. The firm’s quarterly revenue was up .5% on a year-over-year basis. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. As a group, sell-side analysts forecast that Integer Holdings Corporation will post 6.04 earnings per share for the current fiscal year.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.